PARTNERS

Partners

Transport is an innovative specialty pharmaceutical company, with a dermal product pipeline based on the combination of cutting-edge medical electronics, materials engineering, formulation chemistry and skin biology. Our culture thrives on seeking new solutions for the unmet medical needs of patients, focused primarily on dermatological applications.

We have documented success developing proprietary formulations of generic drugs for skincare applications by delivering hundred-fold concentrations of drug safely to the site of activity, dramatically enhancing clinical efficacy and avoiding systemic toxicity. This approach has resulted in a Phase 3 ready solution for the more than 90 million people affected by herpes labialis in the U.S. today. Download Solovir™ ETS Fact Sheet

Our business model is predicated on integrating commercial partnerships to enhance the value of the large (> $ 1 Billion dollar) markets we address. We believe strong collaborations integrating our innovative product design and dermal development expertise with the worldwide commercial expertise of a partner can contribute significantly to long-term growth for both parties.

Our approach is pragmatic:

• We enhance the value of generic drugs with our innovative technologies to expand existing markets.
• We efficiently develop novel products from pre-IND to NDA.
• Our products satisfy large, unmet needs such as herpes labialis, onychomycosis, acne, psoriasis, actinic keratosis, warts, wrinkles, and medical aesthetics.
• We intend to commercialize through strong strategic alliances.

Transport seeks partners whose commercial organizations fit our criteria. We welcome expressions of interest from companies contemplating a partnership with Transport on our clinical-stage opportunities.

Please contact us to initiate a partnership dialogue or meet with us at the upcoming events.

For further information, please contact: partnering@transportpharma.com.